METTL14 and pancreatic neoplasm: For example, METTL14 is decreased in CRC and acts as a tumor suppressor to inhibit cancer cell proliferation, migration, and invasion, while its expression is increased in pancreatic cancer, serving as an oncogene to sustain the tumor growth and metastasis [204–206].